Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Non-Small Cell Lung Cancer Treatment (NSCLC) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Non-Small Cell Lung Cancer Treatment (NSCLC) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Small Cell Lung Cancer Treatment (NSCLC) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-Small Cell Lung Cancer Treatment (NSCLC) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-Small Cell Lung Cancer Treatment (NSCLC) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-Small Cell Lung Cancer Treatment (NSCLC) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Small Cell Lung Cancer Treatment (NSCLC)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Small Cell Lung Cancer Treatment (NSCLC) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc., Astellas Pharma, AstraZeneca, Avid Bioservices Inc. and Bayer Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-Small Cell Lung Cancer Treatment (NSCLC) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Non-Small Cell Lung Cancer Treatment (NSCLC) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Small Cell Lung Cancer Treatment (NSCLC), with revenue, gross margin and global market share of Non-Small Cell Lung Cancer Treatment (NSCLC) from 2018 to 2023.
Chapter 3, the Non-Small Cell Lung Cancer Treatment (NSCLC) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-Small Cell Lung Cancer Treatment (NSCLC) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Small Cell Lung Cancer Treatment (NSCLC).
Chapter 13, to describe Non-Small Cell Lung Cancer Treatment (NSCLC) research findings and conclusion.
This report is a detailed and comprehensive analysis for global Non-Small Cell Lung Cancer Treatment (NSCLC) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Small Cell Lung Cancer Treatment (NSCLC) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-Small Cell Lung Cancer Treatment (NSCLC) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-Small Cell Lung Cancer Treatment (NSCLC) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-Small Cell Lung Cancer Treatment (NSCLC) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Small Cell Lung Cancer Treatment (NSCLC)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Small Cell Lung Cancer Treatment (NSCLC) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc., Astellas Pharma, AstraZeneca, Avid Bioservices Inc. and Bayer Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-Small Cell Lung Cancer Treatment (NSCLC) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Angiogenesis Inhibitor
- Epidermal Growth Factor Receptor Blocker
- Kinase Inhibitor
- Microtubule Stabilizer
- Folate Antimetabolites
- Others
- Adenocarcinoma
- Squamous Cell Carcinoma
- Large Cell Carcinoma
- AbbVie Inc.
- Astellas Pharma
- AstraZeneca
- Avid Bioservices Inc.
- Bayer Healthcare
- Biogen Inc.
- Blueprint Medicines Corp
- Eli Lilly and Company
- Merck & co Inc.
- Novartis
- Pfizer Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Non-Small Cell Lung Cancer Treatment (NSCLC) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Small Cell Lung Cancer Treatment (NSCLC), with revenue, gross margin and global market share of Non-Small Cell Lung Cancer Treatment (NSCLC) from 2018 to 2023.
Chapter 3, the Non-Small Cell Lung Cancer Treatment (NSCLC) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-Small Cell Lung Cancer Treatment (NSCLC) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Small Cell Lung Cancer Treatment (NSCLC).
Chapter 13, to describe Non-Small Cell Lung Cancer Treatment (NSCLC) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-Small Cell Lung Cancer Treatment (NSCLC)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Small Cell Lung Cancer Treatment (NSCLC) by Type
1.3.1 Overview: Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type in 2022
1.3.3 Angiogenesis Inhibitor
1.3.4 Epidermal Growth Factor Receptor Blocker
1.3.5 Kinase Inhibitor
1.3.6 Microtubule Stabilizer
1.3.7 Folate Antimetabolites
1.3.8 Others
1.4 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market by Application
1.4.1 Overview: Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adenocarcinoma
1.4.3 Squamous Cell Carcinoma
1.4.4 Large Cell Carcinoma
1.5 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size & Forecast
1.6 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast by Region
1.6.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Region, (2018-2029)
1.6.3 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
1.6.4 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
1.6.6 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AbbVie Inc.
2.1.1 AbbVie Inc. Details
2.1.2 AbbVie Inc. Major Business
2.1.3 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.1.4 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Inc. Recent Developments and Future Plans
2.2 Astellas Pharma
2.2.1 Astellas Pharma Details
2.2.2 Astellas Pharma Major Business
2.2.3 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.2.4 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Astellas Pharma Recent Developments and Future Plans
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.3.4 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca Recent Developments and Future Plans
2.4 Avid Bioservices Inc.
2.4.1 Avid Bioservices Inc. Details
2.4.2 Avid Bioservices Inc. Major Business
2.4.3 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.4.4 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Avid Bioservices Inc. Recent Developments and Future Plans
2.5 Bayer Healthcare
2.5.1 Bayer Healthcare Details
2.5.2 Bayer Healthcare Major Business
2.5.3 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.5.4 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer Healthcare Recent Developments and Future Plans
2.6 Biogen Inc.
2.6.1 Biogen Inc. Details
2.6.2 Biogen Inc. Major Business
2.6.3 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.6.4 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Biogen Inc. Recent Developments and Future Plans
2.7 Blueprint Medicines Corp
2.7.1 Blueprint Medicines Corp Details
2.7.2 Blueprint Medicines Corp Major Business
2.7.3 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.7.4 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Blueprint Medicines Corp Recent Developments and Future Plans
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.8.4 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly and Company Recent Developments and Future Plans
2.9 Merck & co Inc.
2.9.1 Merck & co Inc. Details
2.9.2 Merck & co Inc. Major Business
2.9.3 Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.9.4 Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck & co Inc. Recent Developments and Future Plans
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.10.4 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novartis Recent Developments and Future Plans
2.11 Pfizer Inc.
2.11.1 Pfizer Inc. Details
2.11.2 Pfizer Inc. Major Business
2.11.3 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.11.4 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-Small Cell Lung Cancer Treatment (NSCLC) by Company Revenue
3.2.2 Top 3 Non-Small Cell Lung Cancer Treatment (NSCLC) Players Market Share in 2022
3.2.3 Top 6 Non-Small Cell Lung Cancer Treatment (NSCLC) Players Market Share in 2022
3.3 Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Overall Company Footprint Analysis
3.3.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Region Footprint
3.3.2 Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Company Product Type Footprint
3.3.3 Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
6.2 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
6.3 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Country
6.3.1 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2029)
6.3.2 United States Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
6.3.3 Canada Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
7.2 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
7.3 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Country
7.3.1 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2029)
7.3.2 Germany Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7.3.3 France Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7.3.5 Russia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7.3.6 Italy Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Region
8.3.1 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2018-2029)
8.3.2 China Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.3 Japan Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.5 India Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.7 Australia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
9.2 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
9.3 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Country
9.3.1 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Country
10.3.1 Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
10.3.4 UAE Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Market Drivers
11.2 Non-Small Cell Lung Cancer Treatment (NSCLC) Market Restraints
11.3 Non-Small Cell Lung Cancer Treatment (NSCLC) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Industry Chain
12.2 Non-Small Cell Lung Cancer Treatment (NSCLC) Upstream Analysis
12.3 Non-Small Cell Lung Cancer Treatment (NSCLC) Midstream Analysis
12.4 Non-Small Cell Lung Cancer Treatment (NSCLC) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Non-Small Cell Lung Cancer Treatment (NSCLC)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Small Cell Lung Cancer Treatment (NSCLC) by Type
1.3.1 Overview: Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type in 2022
1.3.3 Angiogenesis Inhibitor
1.3.4 Epidermal Growth Factor Receptor Blocker
1.3.5 Kinase Inhibitor
1.3.6 Microtubule Stabilizer
1.3.7 Folate Antimetabolites
1.3.8 Others
1.4 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market by Application
1.4.1 Overview: Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adenocarcinoma
1.4.3 Squamous Cell Carcinoma
1.4.4 Large Cell Carcinoma
1.5 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size & Forecast
1.6 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast by Region
1.6.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Region, (2018-2029)
1.6.3 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
1.6.4 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
1.6.6 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AbbVie Inc.
2.1.1 AbbVie Inc. Details
2.1.2 AbbVie Inc. Major Business
2.1.3 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.1.4 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Inc. Recent Developments and Future Plans
2.2 Astellas Pharma
2.2.1 Astellas Pharma Details
2.2.2 Astellas Pharma Major Business
2.2.3 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.2.4 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Astellas Pharma Recent Developments and Future Plans
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.3.4 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca Recent Developments and Future Plans
2.4 Avid Bioservices Inc.
2.4.1 Avid Bioservices Inc. Details
2.4.2 Avid Bioservices Inc. Major Business
2.4.3 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.4.4 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Avid Bioservices Inc. Recent Developments and Future Plans
2.5 Bayer Healthcare
2.5.1 Bayer Healthcare Details
2.5.2 Bayer Healthcare Major Business
2.5.3 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.5.4 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer Healthcare Recent Developments and Future Plans
2.6 Biogen Inc.
2.6.1 Biogen Inc. Details
2.6.2 Biogen Inc. Major Business
2.6.3 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.6.4 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Biogen Inc. Recent Developments and Future Plans
2.7 Blueprint Medicines Corp
2.7.1 Blueprint Medicines Corp Details
2.7.2 Blueprint Medicines Corp Major Business
2.7.3 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.7.4 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Blueprint Medicines Corp Recent Developments and Future Plans
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.8.4 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly and Company Recent Developments and Future Plans
2.9 Merck & co Inc.
2.9.1 Merck & co Inc. Details
2.9.2 Merck & co Inc. Major Business
2.9.3 Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.9.4 Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck & co Inc. Recent Developments and Future Plans
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.10.4 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novartis Recent Developments and Future Plans
2.11 Pfizer Inc.
2.11.1 Pfizer Inc. Details
2.11.2 Pfizer Inc. Major Business
2.11.3 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
2.11.4 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-Small Cell Lung Cancer Treatment (NSCLC) by Company Revenue
3.2.2 Top 3 Non-Small Cell Lung Cancer Treatment (NSCLC) Players Market Share in 2022
3.2.3 Top 6 Non-Small Cell Lung Cancer Treatment (NSCLC) Players Market Share in 2022
3.3 Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Overall Company Footprint Analysis
3.3.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Region Footprint
3.3.2 Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Company Product Type Footprint
3.3.3 Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
6.2 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
6.3 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Country
6.3.1 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2029)
6.3.2 United States Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
6.3.3 Canada Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
7.2 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
7.3 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Country
7.3.1 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2029)
7.3.2 Germany Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7.3.3 France Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7.3.5 Russia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
7.3.6 Italy Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Region
8.3.1 Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2018-2029)
8.3.2 China Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.3 Japan Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.5 India Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
8.3.7 Australia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
9.2 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
9.3 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Country
9.3.1 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Country
10.3.1 Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
10.3.4 UAE Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Market Drivers
11.2 Non-Small Cell Lung Cancer Treatment (NSCLC) Market Restraints
11.3 Non-Small Cell Lung Cancer Treatment (NSCLC) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Industry Chain
12.2 Non-Small Cell Lung Cancer Treatment (NSCLC) Upstream Analysis
12.3 Non-Small Cell Lung Cancer Treatment (NSCLC) Midstream Analysis
12.4 Non-Small Cell Lung Cancer Treatment (NSCLC) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Inc. Company Information, Head Office, and Major Competitors
Table 6. AbbVie Inc. Major Business
Table 7. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 8. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Inc. Recent Developments and Future Plans
Table 10. Astellas Pharma Company Information, Head Office, and Major Competitors
Table 11. Astellas Pharma Major Business
Table 12. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 13. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Astellas Pharma Recent Developments and Future Plans
Table 15. AstraZeneca Company Information, Head Office, and Major Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 18. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. AstraZeneca Recent Developments and Future Plans
Table 20. Avid Bioservices Inc. Company Information, Head Office, and Major Competitors
Table 21. Avid Bioservices Inc. Major Business
Table 22. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 23. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Avid Bioservices Inc. Recent Developments and Future Plans
Table 25. Bayer Healthcare Company Information, Head Office, and Major Competitors
Table 26. Bayer Healthcare Major Business
Table 27. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 28. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bayer Healthcare Recent Developments and Future Plans
Table 30. Biogen Inc. Company Information, Head Office, and Major Competitors
Table 31. Biogen Inc. Major Business
Table 32. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 33. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Biogen Inc. Recent Developments and Future Plans
Table 35. Blueprint Medicines Corp Company Information, Head Office, and Major Competitors
Table 36. Blueprint Medicines Corp Major Business
Table 37. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 38. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Blueprint Medicines Corp Recent Developments and Future Plans
Table 40. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 41. Eli Lilly and Company Major Business
Table 42. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 43. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Eli Lilly and Company Recent Developments and Future Plans
Table 45. Merck & co Inc. Company Information, Head Office, and Major Competitors
Table 46. Merck & co Inc. Major Business
Table 47. Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 48. Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck & co Inc. Recent Developments and Future Plans
Table 50. Novartis Company Information, Head Office, and Major Competitors
Table 51. Novartis Major Business
Table 52. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 53. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Novartis Recent Developments and Future Plans
Table 55. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 56. Pfizer Inc. Major Business
Table 57. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 58. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Pfizer Inc. Recent Developments and Future Plans
Table 60. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million) by Players (2018-2023)
Table 61. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Share by Players (2018-2023)
Table 62. Breakdown of Non-Small Cell Lung Cancer Treatment (NSCLC) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Non-Small Cell Lung Cancer Treatment (NSCLC), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Non-Small Cell Lung Cancer Treatment (NSCLC) Players
Table 65. Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Company Product Type Footprint
Table 66. Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Company Product Application Footprint
Table 67. Non-Small Cell Lung Cancer Treatment (NSCLC) New Market Entrants and Barriers to Market Entry
Table 68. Non-Small Cell Lung Cancer Treatment (NSCLC) Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Share by Type (2018-2023)
Table 71. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Forecast by Type (2024-2029)
Table 72. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023)
Table 73. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Forecast by Application (2024-2029)
Table 74. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Non-Small Cell Lung Cancer Treatment (NSCLC) Raw Material
Table 105. Key Suppliers of Non-Small Cell Lung Cancer Treatment (NSCLC) Raw Materials
Table 1. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Inc. Company Information, Head Office, and Major Competitors
Table 6. AbbVie Inc. Major Business
Table 7. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 8. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Inc. Recent Developments and Future Plans
Table 10. Astellas Pharma Company Information, Head Office, and Major Competitors
Table 11. Astellas Pharma Major Business
Table 12. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 13. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Astellas Pharma Recent Developments and Future Plans
Table 15. AstraZeneca Company Information, Head Office, and Major Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 18. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. AstraZeneca Recent Developments and Future Plans
Table 20. Avid Bioservices Inc. Company Information, Head Office, and Major Competitors
Table 21. Avid Bioservices Inc. Major Business
Table 22. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 23. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Avid Bioservices Inc. Recent Developments and Future Plans
Table 25. Bayer Healthcare Company Information, Head Office, and Major Competitors
Table 26. Bayer Healthcare Major Business
Table 27. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 28. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bayer Healthcare Recent Developments and Future Plans
Table 30. Biogen Inc. Company Information, Head Office, and Major Competitors
Table 31. Biogen Inc. Major Business
Table 32. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 33. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Biogen Inc. Recent Developments and Future Plans
Table 35. Blueprint Medicines Corp Company Information, Head Office, and Major Competitors
Table 36. Blueprint Medicines Corp Major Business
Table 37. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 38. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Blueprint Medicines Corp Recent Developments and Future Plans
Table 40. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 41. Eli Lilly and Company Major Business
Table 42. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 43. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Eli Lilly and Company Recent Developments and Future Plans
Table 45. Merck & co Inc. Company Information, Head Office, and Major Competitors
Table 46. Merck & co Inc. Major Business
Table 47. Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 48. Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck & co Inc. Recent Developments and Future Plans
Table 50. Novartis Company Information, Head Office, and Major Competitors
Table 51. Novartis Major Business
Table 52. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 53. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Novartis Recent Developments and Future Plans
Table 55. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 56. Pfizer Inc. Major Business
Table 57. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product and Solutions
Table 58. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Pfizer Inc. Recent Developments and Future Plans
Table 60. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (USD Million) by Players (2018-2023)
Table 61. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Share by Players (2018-2023)
Table 62. Breakdown of Non-Small Cell Lung Cancer Treatment (NSCLC) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Non-Small Cell Lung Cancer Treatment (NSCLC), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Non-Small Cell Lung Cancer Treatment (NSCLC) Players
Table 65. Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Company Product Type Footprint
Table 66. Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Company Product Application Footprint
Table 67. Non-Small Cell Lung Cancer Treatment (NSCLC) New Market Entrants and Barriers to Market Entry
Table 68. Non-Small Cell Lung Cancer Treatment (NSCLC) Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Share by Type (2018-2023)
Table 71. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Forecast by Type (2024-2029)
Table 72. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023)
Table 73. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Forecast by Application (2024-2029)
Table 74. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Non-Small Cell Lung Cancer Treatment (NSCLC) Raw Material
Table 105. Key Suppliers of Non-Small Cell Lung Cancer Treatment (NSCLC) Raw Materials
LIST OF FIGURES
Figure 1. Non-Small Cell Lung Cancer Treatment (NSCLC) Picture
Figure 2. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type in 2022
Figure 4. Angiogenesis Inhibitor
Figure 5. Epidermal Growth Factor Receptor Blocker
Figure 6. Kinase Inhibitor
Figure 7. Microtubule Stabilizer
Figure 8. Folate Antimetabolites
Figure 9. Others
Figure 10. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application in 2022
Figure 12. Adenocarcinoma Picture
Figure 13. Squamous Cell Carcinoma Picture
Figure 14. Large Cell Carcinoma Picture
Figure 15. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Region in 2022
Figure 20. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Share by Players in 2022
Figure 26. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share in 2022
Figure 28. Global Top 6 Players Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share in 2022
Figure 29. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Share by Type (2018-2023)
Figure 30. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share Forecast by Type (2024-2029)
Figure 31. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Share by Application (2018-2023)
Figure 32. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share Forecast by Application (2024-2029)
Figure 33. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 43. France Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Region (2018-2029)
Figure 50. China Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 53. India Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 67. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Drivers
Figure 68. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Restraints
Figure 69. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Non-Small Cell Lung Cancer Treatment (NSCLC) in 2022
Figure 72. Manufacturing Process Analysis of Non-Small Cell Lung Cancer Treatment (NSCLC)
Figure 73. Non-Small Cell Lung Cancer Treatment (NSCLC) Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Non-Small Cell Lung Cancer Treatment (NSCLC) Picture
Figure 2. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type in 2022
Figure 4. Angiogenesis Inhibitor
Figure 5. Epidermal Growth Factor Receptor Blocker
Figure 6. Kinase Inhibitor
Figure 7. Microtubule Stabilizer
Figure 8. Folate Antimetabolites
Figure 9. Others
Figure 10. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application in 2022
Figure 12. Adenocarcinoma Picture
Figure 13. Squamous Cell Carcinoma Picture
Figure 14. Large Cell Carcinoma Picture
Figure 15. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Region in 2022
Figure 20. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Share by Players in 2022
Figure 26. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share in 2022
Figure 28. Global Top 6 Players Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share in 2022
Figure 29. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Share by Type (2018-2023)
Figure 30. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share Forecast by Type (2024-2029)
Figure 31. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Share by Application (2018-2023)
Figure 32. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share Forecast by Application (2024-2029)
Figure 33. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 43. France Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Region (2018-2029)
Figure 50. China Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 53. India Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Value (2018-2029) & (USD Million)
Figure 67. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Drivers
Figure 68. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Restraints
Figure 69. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Non-Small Cell Lung Cancer Treatment (NSCLC) in 2022
Figure 72. Manufacturing Process Analysis of Non-Small Cell Lung Cancer Treatment (NSCLC)
Figure 73. Non-Small Cell Lung Cancer Treatment (NSCLC) Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
